scholarly journals Decrease in grip strength is associated with the progression of sleep disturbances in chronic liver diseases

2021 ◽  
Vol 3 (2) ◽  
Author(s):  
Hiroki Nishikawa ◽  
Kazunori Yoh ◽  
Hirayuki Enomoto ◽  
Takashi Nishimura ◽  
Shuhei Nishiguchi ◽  
...  
Keyword(s):  
Grip Strength ◽  
Liver Diseases ◽  
Sleep Disturbances ◽  
Chronic Liver ◽  
Chronic Liver Diseases

scholarly journals Grip Strength: A Useful Marker for Composite Hepatic Events in Patients with Chronic Liver Diseases

Diagnostics ◽  
2020 ◽  
Vol 10 (4) ◽  
pp. 238 ◽  
Author(s):  
Kazunori Yoh ◽  
Hiroki Nishikawa ◽  
Hirayuki Enomoto ◽  
Yoshinori Iwata ◽  
Naoto Ikeda ◽  
...  
Keyword(s):  
Grip Strength ◽  
Muscle Mass ◽  
Cumulative Incidence ◽  
Liver Diseases ◽  
Short Form ◽  
Incidence Rates ◽  
Chronic Liver ◽  
Prognostic Impact ◽  
Chronic Liver Diseases

Here we sought to clarify the prognostic impact of sarcopenia-related markers (grip strength (GS), muscle mass using bioimpedance analysis and patient quality of life as assessed by the 36-Item Short-Form Health Survey (SF36)) in patients with chronic liver diseases (CLDs, n = 411; 160 liver cirrhosis patients; median age, 64 years) on the incidence of composite hepatic events (CHEs). A GS decrease was defined as <26 kg in men and <18 kg in women, while a skeletal muscle mass index (SMI) decrease was defined as <7.0 kg/m2 in men and <5.7 kg/m2 in women based on the current guidelines. The physical and metal component summary scores on the SF36 were also included into the analysis. Sixty-two patients (15.1%) had the first incidence of CHEs. The three-year cumulative incidence rates of CHEs in patients with GS decrease or non-decrease were 24.51% and 12.44% (p = 0.0057). The three-year cumulative incidence rates of CHEs in patients with an SMI decrease or non-decrease were 19.65% and 12.99% (p = 0.0982). Multivariate analysis revealed that GS decrease (p = 0.0350) and prothrombin time (p = 0.0293) were significantly associated with the incidence of CHEs. In conclusion, GS can be an independent predictor for CHE development in patients with CLDs.

scholarly journals Decrease of Grip Strength is Associated with Progression of Sleep Disturbance in Chronic Liver Diseases

2020 ◽  
Author(s):  
Hiroki Nishikawa ◽  
Kazunori Yoh ◽  
Hirayuki Enomoto ◽  
Takashi Nishimura ◽  
Shuhei Nishiguchi ◽  
...  
Keyword(s):  
Sleep Disturbance ◽  
Grip Strength ◽  
Liver Diseases ◽  
Chronic Liver ◽  
Chronic Liver Diseases

scholarly journals Predictors for Grip Strength Loss in Patients With Chronic Liver Diseases

In Vivo ◽  
2021 ◽  
Vol 35 (1) ◽  
pp. 363-371
Author(s):  
HIROKI NISHIKAWA ◽  
KAZUNORI YOH ◽  
HIRAYUKI ENOMOTO ◽  
NAOTO IKEDA ◽  
TOMOYUKI TAKASHIMA ◽  
...  
Keyword(s):  
Grip Strength ◽  
Liver Diseases ◽  
Strength Loss ◽  
Chronic Liver ◽  
Chronic Liver Diseases

scholarly journals Reduced grip strength is associated with progression of depressive status in chronic liver diseases

2021 ◽  
Vol 10 (4) ◽  
pp. 21-21
Author(s):  
Hiroki Nishikawa ◽  
Kazunori Yoh ◽  
Hirayuki Enomoto ◽  
Naoto Ikeda ◽  
Tomoyuki Takashima ◽  
...  
Keyword(s):  
Grip Strength ◽  
Liver Diseases ◽  
Chronic Liver ◽  
Chronic Liver Diseases

Helicobacter infection in patients with HCV-chronic liver diseases

2001 ◽  
Vol 120 (5) ◽  
pp. A725-A725
Author(s):  
M DORE ◽  
G REALDI ◽  
D MURA ◽  
D GRAHAM ◽  
A SEPULVEDA
Keyword(s):  
Liver Diseases ◽  
Chronic Liver ◽  
Chronic Liver Diseases

TRAF1-C5as risk locus for increased hepatic fibrosis in chronic liver diseases

2008 ◽  
Vol 46 (09) ◽  
Author(s):  
F Grünhage ◽  
A Höblinger ◽  
S Schwartz ◽  
T Sauerbruch ◽  
F Lammert
Keyword(s):  
Hepatic Fibrosis ◽  
Liver Diseases ◽  
Chronic Liver ◽  
Chronic Liver Diseases ◽  
Risk Locus

Targeting TGF-β2 in chronic liver diseases

2015 ◽  
Vol 53 (01) ◽  
Author(s):  
A Dropmann ◽  
H Korhonen ◽  
F Jaschinski ◽  
M Janicot ◽  
N Meindl-Beinker ◽  
...  
Keyword(s):  
Liver Diseases ◽  
Chronic Liver ◽  
Chronic Liver Diseases
Sign in / Sign up

Export Citation Format

Share Document